Home » Newsletters » BioWorld

BioWorld

Feb. 19, 1993

View Archived Issues

SBIR FOR DRUG TO TREAT BRAIN DEATH

APPOINTMENTS AND ADVANCEMENTS

MULTINATIONAL HEPATITIS B TRIALS

VICAL GETS PATENT ALLOWANCE

HEMOSOL READIES PUBLIC OFFERING

BIOINSECTICIDE APPROVED IN MEXICO

FACTOR VIII-C PATENT UPHELD

CAUTIOUS RESPONSE TO CLINTON'S PLAN

CAMBRIDGE BIOTECH SEEKS TO PULL REGISTRATION

GROWTH HORMONE DESIGNATED ORPHAN DRUG

CEL-SCI PACT FOR MANUFACTURING PLANT

IBA MEMBERS RATIFY MERGER WITH ABC

CARTILAGE, BONE TISSUE GROWN IN VITRO

APPLIED BIOSYSTEMS MERGER OFFICIAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...